Abstract:Alexithymia is a psychological trait characterised by difficulty in perceiving and expressing emotions and body sensations. Failure to perceive dyspnoea could lead alexithymic asthmatics to underestimate the severity of an asthma exacerbation, and thereby increase the risk of developing a fatal or near-fatal asthma (NFA) attack. The objective of the present study was to determine the prevalence of alexithymia in NFA patients and to analyse their clinical characteristics.Alexithymia was assessed using the Toron… Show more
“…These patients include those who: 1) have a history of near-fatal asthma requiring intubation and mechanical ventilation [323]; 2) have had a hospitalisation or emergency care visit for asthma in the previous year; 3) are currently using or have recently stopped using oral glucocorticosteroids; 4) are not currently using inhaled glucocorticosteroids [324]; 5) are overdependent on rapid-acting inhaled b 2 -agonists, especially those who use more than one canister of salbutamol (or equivalent) monthly [325]; 6) have a history of psychiatric disease or psychosocial problems [326], including the use of sedatives [327]; and 7) have a history of noncompliance with an asthma medication plan.…”
Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled ''A Global Strategy for Asthma Management and Prevention'', first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that ''it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained,'' and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient-care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.
“…These patients include those who: 1) have a history of near-fatal asthma requiring intubation and mechanical ventilation [323]; 2) have had a hospitalisation or emergency care visit for asthma in the previous year; 3) are currently using or have recently stopped using oral glucocorticosteroids; 4) are not currently using inhaled glucocorticosteroids [324]; 5) are overdependent on rapid-acting inhaled b 2 -agonists, especially those who use more than one canister of salbutamol (or equivalent) monthly [325]; 6) have a history of psychiatric disease or psychosocial problems [326], including the use of sedatives [327]; and 7) have a history of noncompliance with an asthma medication plan.…”
Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled ''A Global Strategy for Asthma Management and Prevention'', first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that ''it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained,'' and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient-care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.
“…Research suggests that alexithymia might play a role in the onset or development of several psychiatric and physical health problems such as substance abuse or pathological gambling [3,4,5], eating [6,7] and somatoform disorders [8,9], chronic pain [10], low back pain [11] or kidney failure [12], posttraumatic stress disorders [13,14] and stress-related disorders in general [15], asthma [16], myocardial infarction [17], inflammatory bowel disease [18], and also cancer [19]. Furthermore alexithymia is suspected to have an impact on treatment compliance and treatment outcome [20].…”
Objective: To summarize the literature on alexithymia in cancer patients. Methods: The empirical literature published between 1972 and January 2010 was searched through MEDLINE, PSYINFO, EMBASE and the Cochrane Library. Key words were: alexithymia, affective symptoms, cancer, neoplasms. Results: The search identified 16 relevant studies which are methodologically problematic and show conflicting results. However, several interesting hypotheses emerge such as a possible link between alexithymia and the immune system, between alexithymia and quality of life, or between alexithymia, anxiety and depression. The question to what degree alexithymia in cancer patients is a trait or a state cannot be answered by these studies. Conclusions: A lack of methodologically sound studies and the large variations of results among studies suggest that the role of alexithymia in patients with cancer deserves more systematic research. Consequently, studies are needed which investigate the nature (state or trait) of alexithymia, its impact on cancer development and progression, as well as its influence on compliance and on the underestimation of psychological distress and psychiatric outcome in cancer patients.
“…Psychosocial factors may be associated with poorly controlled and potentially fatal asthma. 36,37,46,68,69 Patients with a poor perception of dyspnea have been identified in some 62,64,79 but not all 27,36,63 studies of risk factors for potentially fatal asthma, but there is no simple, validated way to test for this factor in a primary care setting. 101 Failure of the treating physician to appreciate the severity of the acute asthma attack and to initiate appropriately aggressive therapy has also been shown to be a risk factor for a fatal outcome.…”
Section: The Case Continuedmentioning
confidence: 99%
“…History of multiple visits to the emergency department for asthma 38,39,46 II-2 Failure to consult family physician for worsening asthma 27,29,40,42,47 II-2…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.